Skip to main content

Table 6 Associations between post-transplantation mortality with infections and treatments

From: Epidemiology of early infections and predictors of mortality after autologous hematopoietic stem-cell transplantation among multiple myeloma, Hodgkin, and non-Hodgkin lymphoma: the first experience from Palestine

Infection/treatment

N

%

Post-transplantation mortality

Fisher’s exact test

p-value

No

Yes

n

%

n

%

Microorganism

 Escherichia coli

  No

136

93.8

133

91.7

3

2.1

10.1

0.031

  Yes

9

6.2

7

4.8

2

1.4

 Klebsiella pneumoniae

  No

139

95.9

136

93.8

3

2.1

16.7

0.014

  Yes

6

4.1

4

2.8

2

1.4

 Staphylococcus epidermidis

  No

143

98.6

139

95.9

4

2.8

13.1

0.068

  Yes

2

1.4

1

0.7

1

0.7

 Fungal pneumonia

  No

143

98.6

139

95.9

4

2.8

13.1

0.068

  Yes

2

1.4

1

0.7

1

0.7

 Gram-negative bacteria

  No

130

89.7

128

88.3

2

1.4

13.7

0.008

  Yes

15

10.3

12

8.3

3

2.1

Treatment

 Amikacin

  No

47

32.4

43

29.7

4

2.8

5.3

0.038

  Yes

98

67.6

97

66.9

1

0.7

 Voriconazole

  No

126

86.9

124

85.5

2

1.4

9.9

0.016

  Yes

19

13.1

16

11.0

3

2.1

 Colistin

  No

114

78.6

113

77.9

1

0.7

10.5

0.008

  Yes

31

21.4

27

18.6

4

2.8

 Caspofungin

  No

133

91.7

131

90.3

2

1.4

18.1

0.004

  Yes

12

8.3

9

6.2

3

2.1